Dopaminergic gene expression during amphetamine withdrawal

Antonio M. Persico, Charles W. Schindler, Michael T. Brannock, Antonio M. Gonzalez, Christopher K. Surratt, George R. Uhl

Research output: Contribution to journalArticlepeer-review

Abstract

Animals and humans display a constellation of behavioral and neurochemical signs after termination of psychostimulant administration. Amphetamine withdrawal could involve the dopaminergic systems that are thought to underlie psychostimulant rewarding effects, and may thus conceivably alter expression of key genes for dopaminergic transmission, including those encoding tyrosine hydroxylase (TH), the membrane dopamine transporter (DAT) and the synaptic vesicle amine transporter (SVAT). Withdrawal from 7.5 mg kgs-1 i.p. amphetamine (b.i.d. for a two week duration) yields no significant changes in rat DAT mRNA. TH mRNA levels are modestly enhanced over the same week of withdrawal, during which dopamine levels and behavioral novelty responses are both depressed. SVAT expression is significantly blunted following chronic amphetamine treatment. Altered TH and/or SVAT gene expression might contribute to restoring normal function to neurons "withdrawing" from amphetamine treatments.

Original languageEnglish
Pages (from-to)41-44
Number of pages4
JournalNeuroReport
Volume4
Issue number1
Publication statusPublished - 1993

Keywords

  • Amphetamine
  • Dopamine transporter
  • Gene expression
  • Psychostimulant
  • Synaptic vesicular amine transporter
  • Tyrosine hydroxylase
  • Withdrawal

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Dopaminergic gene expression during amphetamine withdrawal'. Together they form a unique fingerprint.

Cite this